MRI's changing role in radiotherapy
Prof. Dr. Uulke van der Heide describes MR’s changing role in radiotherapy and his collaboration with Philips to bring MR-only simulation for RT planning from the lab to the clinic. The Philips Ingenia MR-RT platform now supports MR-only simulation for planning the treatment of prostate cancer patients.
Prof. Dr. van der Heide is a medical physicist at the Netherlands Cancer Institute in Amsterdam.